Veritas Investment Management Llp Has Decreased Oracle (ORCL) Position; Amerisourcebergen (ABC) Sellers Decreased By 7.35% Their Shorts

February 19, 2018 - By Nellie Frank

Veritas Investment Management Llp decreased Oracle Corp (ORCL) stake by 4.08% reported in 2017Q3 SEC filing. Veritas Investment Management Llp sold 35,075 shares as Oracle Corp (ORCL)’s stock rose 5.35%. The Veritas Investment Management Llp holds 824,495 shares with $39.84 million value, down from 859,570 last quarter. Oracle Corp now has $209.92B valuation. The stock increased 0.14% or $0.07 during the last trading session, reaching $50.71. About 11.10 million shares traded. Oracle Corporation (NYSE:ORCL) has risen 14.08% since February 19, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

Amerisourcebergen Corporation (NYSE:ABC) had a decrease of 7.35% in short interest. ABC’s SI was 9.84 million shares in February as released by FINRA. Its down 7.35% from 10.62 million shares previously. With 1.80M avg volume, 6 days are for Amerisourcebergen Corporation (NYSE:ABC)’s short sellers to cover ABC’s short positions. The SI to Amerisourcebergen Corporation’s float is 6.16%. The stock increased 2.24% or $2.18 during the last trading session, reaching $99.4. About 2.79 million shares traded or 39.52% up from the average. AmerisourceBergen Corporation (NYSE:ABC) has risen 18.80% since February 19, 2017 and is uptrending. It has outperformed by 2.10% the S&P500.

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. The company has market cap of $21.84 billion. The Company’s Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It has a 22.49 P/E ratio. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers.

Among 20 analysts covering AmerisourceBergen (NYSE:ABC), 11 have Buy rating, 0 Sell and 9 Hold. Therefore 55% are positive. AmerisourceBergen had 69 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Friday, October 27 by Jefferies. The firm has “Buy” rating by Needham given on Tuesday, January 30. The rating was upgraded by TheStreet to “Buy” on Monday, July 27. Robert W. Baird maintained the stock with “Buy” rating in Wednesday, January 17 report. Jefferies maintained the stock with “Hold” rating in Wednesday, June 21 report. The firm has “Buy” rating by Leerink Swann given on Monday, August 7. The rating was maintained by Jefferies on Thursday, July 27 with “Hold”. The company was maintained on Friday, February 5 by UBS. The stock of AmerisourceBergen Corporation (NYSE:ABC) earned “Mkt Perform” rating by Leerink Swann on Friday, November 4. The firm has “Neutral” rating given on Tuesday, June 7 by Bank of America.

Analysts await Oracle Corporation (NYSE:ORCL) to report earnings on March, 21. They expect $0.66 EPS, up 4.76% or $0.03 from last year’s $0.63 per share. ORCL’s profit will be $2.73 billion for 19.21 P/E if the $0.66 EPS becomes a reality. After $0.62 actual EPS reported by Oracle Corporation for the previous quarter, Wall Street now forecasts 6.45% EPS growth.

Among 38 analysts covering Oracle (NYSE:ORCL), 28 have Buy rating, 0 Sell and 10 Hold. Therefore 74% are positive. Oracle had 105 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Outperform” rating by BMO Capital Markets given on Friday, December 15. BMO Capital Markets maintained it with “Market Perform” rating and $45 target in Wednesday, March 16 report. The firm has “Buy” rating by UBS given on Thursday, November 9. UBS maintained Oracle Corporation (NYSE:ORCL) rating on Thursday, June 22. UBS has “Buy” rating and $5200 target. The rating was maintained by Wedbush on Thursday, March 16 with “Neutral”. On Friday, December 16 the stock rating was maintained by Wedbush with “Neutral”. The firm has “Outperform” rating given on Wednesday, January 11 by Wells Fargo. The firm has “Hold” rating given on Thursday, September 17 by Wunderlich. Piper Jaffray maintained the stock with “Buy” rating in Thursday, February 15 report. As per Monday, July 24, the company rating was maintained by Stifel Nicolaus.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: